Cardiac and Pulmonary Transplant Considerations During COVID-19 Pandemic

Abstract

Get full access to this article

View all access options for this article.

References

International Society of Heart and Lung Transplantation . Guidance from the International Society of Heart and Lung Transplantation regarding the SARS CoV-2 pandemic, https://ishlt.org/ishlt/media/documents/SARS-CoV-2_-Guidance-for-Cardiothoracic-Transplant-and-VAD-centers.pdf (2020, accessed 20 May 2020).

American Society of Transplantation . 2019-nCoV (Coronavirus): Recommendations and Guidance for Organ Donor Testing, https://www.myast.org/sites/default/files/internal/COVID19%20FAQ%20Donor%20Testing%2005.14.2020.pdf (2020, accessed 20 May 2020).

Latif

Farr

MA.

Clerkin

et al. Characteristics and outcomes of recipients of heart transplant with coronavirus disease 2019. JAMA Cardiol. Epub ahead of print 13 May 2020. DOI: 10.1001/jamacardio.2020.2159

32402056

The OpenSAFELY Collaborative, Williamson

Walker

et al. OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. Preprint at medRxiv. Epub ahead of print 7 May 2020. DOI: 10.1101/2020.05.06.20092999